The high-performance single-seater 777 hypercar is born in Monza
(Monza, Italy): – The 777 hypercar is a new Italian hypercar born of the excellent partnership with Andrea Levy, Dallara, and Gibson, built from technology used in motorsports and all informations and images are on www.777hypercar.com.
777 hypercar is built by 777 Motors, the car manufacturer based in the Autodromo Nazionale Monza and founded by Andrea Levy, an entrepreneur, car collector, racing driver, and president of MIMO Milano Monza Motorshow. The 777 hypercar project will be presented on November 22, limited to just 7 units, each of which will cost 7 million euros.
777 hypercar is at the top for performance thanks to an FIA-homologated carbon monocoque developed by Dallara, which generate an incredible downforce of 2,100 kg at a speed of 370 km/h, an extremely low weight of 900 kg, and a lateral acceleration from 3.5 to 4 g that keeps the car glued to the asphalt, giving an incredible estimate lap time of just 1 minute and 33 seconds in the Monza Circuit. The engine is a naturally aspirated V8, 4,500 cc of displacement, which develops 730 hp at 9,000 rpm, powered by synthetic fuels.
Along with the 777 hypercar, owners will also receive custom attire and machinery, tailored to their liking. An advanced machine is created for ad hoc to reinforce the neck area.
Data sheet 777 hypercar engineered by Dallara:
Headquarters: Autodromo Nazionale di Monza, the Temple of Speed
Chassis: FIA-homologated carbon monocoque
Engine: 8 V-cylinders
Displacement: 4,500 cc
Power: 730 hp at 9,000 rpm
Top speed: 370 km / h.
Weight: 900 kg
Lateral acceleration: 3.5 / 4.0 g.
Downforce: 2,100 kg at 370 km / h
Monza lap time: 1m33s
Limited edition of seven units
Price: 7 million euros
Delivery: from 2025
Contacts
Barbara SantisePress Contact777 hypercar
barbara.santise@777hypercar.comhttps://www.777hypercar.comImages
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
New management for the EUTOP Group22.4.2024 10:51:42 CEST | Press release
Stefan Mappus is the new Managing Director of the EUTOP Group. Together with long-standing Managing Director Christian Schaufler, he will manage the fortunes of the Group from now on. Stefan Mappus is responsible for EUTOP's client business as a member of the management board and thus brings his wealth of experience in politics, administration and business directly to the benefit of EUTOP's clients.
Additional partnership in medical technology: Bosch and R-Biopharm to strengthen Vivalytic analysis platform Plans to use innovative Bosch BioMEMS technology in PCR tests for multiresistant bacteria18.4.2024 10:15:00 CEST | Press release
Bosch and R-Biopharm are jointly investing 150 million euros in the development of new PCR tests and in marketing. PCR test for multiresistant gram-negative (MRGN) bacteria to be developed using novel BioMEMS technology. BioMEMS chips permit simultaneous testing of up to 250 genetic characteristics – in some cases, in less than 15 minutes. Darmstadt, Gerlingen, and Waiblingen, Germany – The market for medical technology is innovative, dynamic, and growing. Bosch sees medical technology as a strategic growth field and intends to expand its Bosch Healthcare Solutions subsidiary, based in Waiblingen. Bosch has now entered into a new partnership with the German diagnostics solutions company R-Biopharm. This partnership will be focused on Bosch’s universal, fully automated Vivalytic molecular diagnostic analysis platform. The two companies will invest a total of 150 million euros by the end of the decade. Within their strategic development and distribution partnership, the partners intend t
Elatec Brings Employee Badge for Apple Wallet to Users17.4.2024 08:45:03 CEST | Press release
Munich, April 17, 2024 – Elatec today announced it is bringing employee badge in Apple Wallet to its customers, enabling an organization’s employees or tenants to unlock access to locations and devices with a simple tap of their iPhone or Apple Watch. Powered by Elatec’s Mobile Credential Manager software, which works hand-in-hand with Elatec’s universal RFID readers, this brings together the world’s most powerful and versatile readers with the best mobile access system available. Employee badge in Apple Wallet helps deliver a convenient and contactless experience for users. Once enabled, employee badge in Apple Wallet allows users to seamlessly and securely add their employee badge to Apple Wallet, and hold their iPhone or Apple Watch near an NFC reader to unlock office doors, turnstiles, elevators and key card-protected amenity spaces — eliminating the need to open an app or present a traditional, plastic access key. With Express Mode, employees do not need to unlock their device to
National Research Center for Applied Cybersecurity ATHENE: Severe Vulnerabilities Discovered in Software to Protect Internet Routing12.4.2024 08:49:14 CEST | Press release
A research team from the National Research Center for Applied Cybersecurity ATHENE led by Prof. Dr. Haya Schulmann has uncovered 18 vulnerabilities in crucial software components of Resource Public Key Infrastructure (RPKI). RPKI is an Internet standard meant to protect Internet traffic from being hijacked by hackers. By now, all affected vendors provided patches for their products. The vulnerabilities could have had devastating consequences: Internet hijacks have already been exploited, e.g., for phishing passwords and other sensitive information, tricking certificate authorities into issuing fraudulent Web certificates, stealing cryptocurrency, distributing malware, and poisoning caches of DNS servers.
Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment10.4.2024 11:00:00 CEST | Press release
The launch in Germany through its step-down subsidiary betapharm marks Dr. Reddy's entry into digital therapeutics in Europe. Nerivio® is the first REN (wearable, FDA-cleared, and CE-marked for acute and/or prevention migraine (with or without aura) treatment for adults and adolescents (≥ 12 years). Nerivio® is worn on the upper arm during treatment and controlled by a smartphone app, making it comfortable and portable. Starting with Germany, followed by Spain and the UK, Dr. Reddy's plans to further increase access to Nerivio® in European countries.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom